Indegene Ltd.

Financial

	Indegene	Syngene Internation.	Jubilant Pharmova
Operational Metrics
Software Services
Active Clients	63.0 .	n/a	n/a
Financials
5 yr Average ROE	26.35 %	12.33 %	8.35 %
5yr average Equity Multiplier	1.68	1.57	2.0
5yr Average Asset Turnover Ratio	1.21	0.52	0.59
5yr Avg Net Profit Margin	12.84 %	15.3 %	7.13 %
Price to Book	4.99	6.08	3.04
P/E	29.98	56.68	567.28
5yr Avg Cash Conversion Cycle	89.95 Days	-6453.7 Days	-19.21 Days
Inventory Days	0.0	20.52 Days	81.78 Days
Days Receivable	89.95 Days	48.33 Days	51.11 Days
Days Payable	0.0	-264.76 Days	173.51 Days
5yr Average Interest Coverage Ratio	24.33	16.15	3.98
5yr Avg ROCE	34.13 %	13.11 %	9.05 %
5yr Avg Operating Profit Margin	19.32 %	29.04 %	18.69 %
5 yr average Debt to Equity	0.15	0.15	0.64
5yr CAGR Net Profit	22.17 %	4.15 %	-38.8 %
5yr Average Return on Assets	15.63 %	7.88 %	4.23 %
Shareholdings
Promoter Holding	0.0	52.68 %	47.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-17.61 %	-3.0 %
Change in Mutual Fund Holding (3 Yrs)	1.09 %	17.91 %	5.97 %

Business

	Indegene	Syngene Internation.	Jubilant Pharmova
Product Wise Break-Up	Product Wise Break-Up Enterprise Commercial Solutions 56.3 Enterprise Medical Solutions 27.9 Omnichannel Activation 12.8 CDMO 0 Discovery Services 0 Dedicated Centres 0 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Others 3.0	Product Wise Break-Up Specialty intermediates 0 0 Contract Research & Contract Manufacturing (CRAMS) 96.59 Life science chemicals 0 0 Nutritional products 0 Dedicated Centres 0 Radiopharmaceuticals 0 Allergy therapy products 0 Enterprise Commercial Solutions 0 Active pharmaceutical ingredients 0 CDMO 0 Omnichannel Activation 0 Discovery Services 0 India Branded pharmaceuticals 0 Solid dosage formulations 0 Enterprise Medical Solutions 0 Others 3.41	Product Wise Break-Up Specialty intermediates 0 Contract Research and Development Services 6.7 0 Life science chemicals 0 Contract Manufacturing 16.81 Nutritional products 0 Dedicated Centres 0 Radiopharmaceuticals 44.9 Anti-allergic 10.21 Enterprise Commercial Solutions 0 Active Pharmaceutical Ingredient (API) 9.26 CDMO 0 Omnichannel Activation 0 Discovery Services 0 India branded pharmaceuticals 0.72 Solid dosage formulations 10.82 Enterprise Medical Solutions 0 Others 0.58
Location Wise Break-Up	Location Wise Break-Up North America 71.9 Europe 24.6 India 0.9 Rest of the World 0 Japan 0 USA 0 China 0 Americas and Europe 0 Others 2.6	Location Wise Break-Up Rest of the World 4.25 Europe 32.05 India 1.77 Japan 0 Americas and Europe 0 North America 0 China 0 USA 61.93	Location Wise Break-Up Rest of the World 7.5 Europe 0 India 2.33 Japan 0 Americas and Europe 90.17 North America 0 China 0 USA 0
Operating Profit Break-Up	Operating Profit Break-Up Enterprise Commercial Solutions 57.84 Enterprise Medical Solutions 34.55 Omnichannel Activation 7.6 Generics 0 CDMO Sterile Injectables 0 Allergy Immunotherapy 0 Radiopharma 0 Proprietary Novel Drugs 0 Contract Research and Development 0 Life Science Ingredients 0 Pharmaceuticals 0 Others 0.01	-	Operating Profit Break-Up Proprietary Novel Drugs 0 Generics 0 Pharmaceuticals 0 Radiopharma 32.37 CDMO Sterile Injectables 23.64 Enterprise Commercial Solutions 0 Life Science Ingredients 0 Allergy Immunotherapy 26.93 Omnichannel Activation 0 Contract Research and Development 17.05 Enterprise Medical Solutions 0 Others 0.01
Verticals	Verticals BioPharmaceuticals 94.0 Medical Devices Companies 2.6 Emerging biotech Companies 2.3 Others 1.1	-	-

Indegene Ltd.

SIGN UP FOR FREE